Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1151 | Neuroendocrinology | ICEECE2012

PTHrP-induced hypercalcemia: a rare and challenging presentation in metastatic pancreatic neuroendocrine tumour

Pan S. , Curran S. , Corrie P. , Simpson H.

Introduction: Hypercalcemia due to parathyroid-hormone-related-peptide (PTHrP) is rare in neuroendocrine tumours.A 63-year-old lady initially presented to ENT surgeons with symptoms of reflux, dysphagia, and weight loss. Past medical history included hysterectomy eight years previously for uterine prolapse. There was no family history of note. Investigations revealed corrected calcium was elevated at 2.94 (2.1–2.5) mmol/l. ALP: 184 (30–135) U/l...

ea0031p168 | Neoplasia, cancer and late effects | SFEBES2013

Review of patients with adrenocortical carcinoma at a tertiary referral centre

Deshpande S , Parker V , Ahmed U , Moore D , Jamieson N V , Gurnell M G , Chatterjee V K , Basu B , Corrie P , Simpson H L

Introduction: Adrenocortical carcinoma (ACC) is a rare but devastating malignancy. We performed a review to determine outcome in our patient cohort.Of 20 patients 14 were females, six males. Median overall survival was 27.5 months (range 1–168), nine being deceased. Mean age at presentation 52.3 years (range 18–71). The majority of cancers were large; 5% ≤5 cm, 40% 5–10 cm, 55 >10 cm. 25% had stage IV disease, 10% stage III, 55% ...